A Clinical Study Comparing SG301 Plus Pomalidomide and Dexamethasone to Placebo Plus Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma Patients | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Clinical Study Comparing SG301 Plus Pomalidomide and Dexamethasone to Placebo Plus Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma Patients	Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease	Recruiting	Phase 3	2026-07-10		NCT06508983

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Hangzhou Sumgen Biotech Co., Ltd.	8

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Beijing Chaoyang Hospital of Capital Medical University	Beijing	China	1
First Affiliated Hospital of Henan University of Science and Technology	Luoyang	China	2
Guangzhou First People's Hospital	Guangzhou	China	5
Henan Cancer Hospital	Zhengzhou	China	76
Shanxi Provincial Hospital	Taiyuan	China	1
Sun Yat-sen University Cancer Center	Guangzhou	China	61
The First Affiliated Hospital of Soochow University	Suzhou	China	101
The Second Affiliated Hospital Of Xi an Jiaotong University (Xibei Hospital)	Xi’an	China	2
The Second Affiliated Hospital Zhejiang University School Of Medicine	Hangzhou	China	2
Tianjin Cancer University Airport Hospital	Tianjin	China	1
Tianjin Medical University Cancer Institute & Hospital	Tianjin	China	58
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Wuhan	China	37